Authors:
Drake, WM
Parkinson, C
Akker, SA
Monson, JP
Besser, GM
Trainer, PJ
Citation: Wm. Drake et al., Successful treatment of resistant acromegaly with a growth hormone receptor antagonist, EUR J ENDOC, 145(4), 2001, pp. 451-456
Citation: R. Jordan et C. Parkinson, Reflective practice in a process for the re-approval of ASWs: an exploration of some inevitable resistance, J SOC WOR P, 15(1), 2001, pp. 67-79
Citation: C. Parkinson et al., The relationship between serum GH and serum IGF-I in acromegaly is gender-specific, J CLIN END, 86(11), 2001, pp. 5240-5244
Citation: C. Parkinson et Pj. Trainer, Pegvisomant: a growth hormone receptor antagonist for the treatment of acromegaly, GROWTH H I, 10, 2000, pp. 119-123
Authors:
Trainer, PJ
Drake, WM
Katznelson, L
Freda, PU
Herman-Bonert, V
van der Lely, AJ
Dimaraki, EV
Stewart, PM
Friend, KE
Vance, ML
Besser, GM
Scarlett, JA
Thorner, MO
Parkinson, C
Klibanski, A
Powell, JS
Barkan, AL
Sheppard, MC
Maldonado, M
Rose, DR
Clemmons, DR
Johannson, G
Bengtsson, BA
Stavrou, S
Kleinberg, DL
Cook, DM
Phillips, LS
Bidlingmaier, M
Strasburger, CJ
Hackett, S
Zib, K
Bennett, WF
Davis, RJ
Citation: Pj. Trainer et al., Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant, N ENG J MED, 342(16), 2000, pp. 1171-1177
Authors:
Handy, BN
Acton, LW
Kankelborg, CC
Wolfson, CJ
Akin, DJ
Bruner, ME
Caravalho, R
Catura, RC
Chevalier, R
Duncan, DW
Edwards, CG
Feinstein, CN
Freeland, SL
Friedlaender, FM
Hoffmann, CH
Hurlburt, NE
Jurcevich, BK
Katz, NL
Kelly, GA
Lemen, JR
Levay, M
Lindgren, RW
Mathur, DP
Meyer, SB
Morrison, SJ
Morrison, MD
Nightingale, RW
Pope, TP
Rehse, RA
Schrijver, CJ
Shine, RA
Shing, L
Strong, KT
Tarbell, TD
Title, AM
Torgerson, DD
Golub, L
Bookbinder, JA
Caldwell, D
Cheimets, PN
Davis, WN
Deluca, EE
McMullen, RA
Warren, HP
Amato, D
Fisher, R
Maldonado, H
Parkinson, C
Citation: Bn. Handy et al., The transition region and coronal explorer, SOLAR PHYS, 187(2), 1999, pp. 229-260